🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Thermo Fisher Scientific Inc.

TMO Healthcare
$641.39 +$28.24 (4.61%)
Market Cap: $237.15 B
Gurus Holding
22
Popularity Rank
#23
% of Shares Held
2.68%
Net Activity (Q2 2026)
+$135.51 M

Guru Ownership Trend

Guru Analysis for Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 22 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.35 B.

Top institutional holders include Ken Fisher and Jeremy Grantham.

Notably, Larry Robbins has expressed high conviction in this stock, allocating 5.73% of their equity portfolio to it.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $135.51 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 426.4%. Conversely, Diamond Hill Capital reduced exposure by 30.0%.

Key Holders

Top 5 by Value

$1.46 B
$1.37 B
$971.34 M
$314.47 M
$139.25 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$684.11 M
Total Buy Value
New Buys 1
Additions 12
-$548.6 M
Total Sell Value
Reductions 6
Sold Out 3

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
9
Net Buyers
13

FAQs for Thermo Fisher Scientific Inc. (TMO)

Major holders include Ken Fisher ($1.46 B), Jeremy Grantham ($1.37 B), Andreas Halvorsen ($971.34 M). According to the latest reported data, 22 tracked investment managers collectively hold approximately 9.9 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $135.51 M, with 13 managers increasing positions and 9 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 3 fully exited TMO. The total reported sell value was $548.6 M.

Yes, 1 managers opened new positions in TMO, and 12 increased their existing holdings. The total reported buy value was $684.11 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.44% Add 2.3% 2,915,715 $1.46 B Q2 2026
3.09% Add 9.5% 2,739,191 $1.37 B Q2 2026
2.77% Add 16.2% 1,937,415 $971.34 M Q2 2026
5.73% Add 150.4% 627,240 $314.47 M Q2 2026
0.15% Reduce -21.4% 277,735 $139.25 M Q2 2026
0.04% Add 105.2% 257,910 $128.99 M Q2 2026
1.01% Reduce -30.0% 252,559 $126.62 M Q2 2026
1.54% Add 11.9% 248,244 $124.46 M Q2 2026
0.64% Add 252.3% 193,340 $96.93 M Q2 2026
0.16% Add 36.7% 139,499 $69.94 M Q2 2026
4.00% Reduce -4.8% 115,200 $57.76 M Q2 2026
0.28% Add 8.9% 73,100 $36.65 M Q2 2026
0.05% Add 426.4% 71,244 $35.72 M Q2 2026
0.18% New Buy 19,200 $9.63 M Q2 2026
1.51% Add 1.0% 14,289 $7.16 M Q2 2026
0.03% Reduce -10.6% 12,948 $6.49 M Q2 2026
0.02% Reduce -10.4% 4,060 $2.04 M Q2 2026
0.06% 1,389 $696,389 Q2 2026
0.01% 1,241 $622,188 Q2 2026
0.27% Add 14.3% 750 $376,020 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form